Evidence map›Paper›PMID 42268916›Full record

ArticlePloS one2026

Multi-scale feature integration with enhanced cytomorph for high-accuracy cervical cytology classification.

Elif İlgazi Kılıç, Şafak Kılıç

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elif İlgazi KılıçDepartment of Obstetrics and Gynecology, Kayseri City Hospital, Kayseri, Türkiye.ORCID https://orcid.org/0009-0002-1468-4944
Şafak KılıçSchool of Computer Science, CHART Laboratory, University of Nottingham, Nottingham, United Kingdom.ORCID https://orcid.org/0000-0002-2014-7638

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate classification of cervical cytology images plays a crucial role in early detection and prevention of cervical cancer, which remains a significant global health challenge. Despite advancements in deep learning for medical image analysis, the unique characteristics of cervical cells, including subtle morphological differences and complex nuclear patterns, pose considerable challenges for automated classification systems. In this paper, we present a novel deep learning architecture specifically designed for cervical cytology image classification. Our approach integrates three key components: (1) a specialized data augmentation pipeline tailored for cytopathology images, (2) a Morphology Attention Module (MAM) that captures multi-scale cellular features with adaptive feature fusion, and (3) a Spatial-Channel Mixer (SCM) that efficiently encodes nuclear neighborhood spatial information. Extensive experiments on both the SIPaKMeD and Mendeley LBC datasets demonstrate the superior performance of our model, achieving state-of-the-art accuracy of 99.06% on the 5-class SIPaKMeD dataset and 98.55% on the Mendeley LBC dataset. Importantly, our approach reduces error rates by up to 82.5% compared to conventional CNN architectures and 61.8% compared to recent Vision Transformer approaches. The proposed architecture demonstrates robust generalization across different cell types and imaging conditions, making it a promising tool for enhancing cervical cancer screening programs. Our work contributes to the advancement of automated cytology analysis and has the potential to improve early detection of cervical abnormalities, particularly in resource-limited settings where expert cytopathologists may be scarce.

Indexed as

Cervix UteriImage Processing, Computer-AssistedUterine Cervical NeoplasmsDeep LearningFemaleHumans

Identifiers

PMID42268916
PMCPMC13252754

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.